<DOC>
	<DOCNO>NCT02934997</DOCNO>
	<brief_summary>To determine role dysfunctional high density lipoprotein ( Dys-HDL ) predict mediate progression chronic critical illness morbid long-term outcome patient treat community-acquired hospital-acquired sepsis .</brief_summary>
	<brief_title>The Role Dysfunctional HDL Sepsis</brief_title>
	<detailed_description>The long-term goal research program characterize antecedent mediator morbid long-term outcome patient sepsis . Despite successful early management , sepsis disease high incidence chronic critical illness ( CCI - intensive care unit stay ≥ 14 day organ dysfunction ) morbid long-term outcome ( functional dependence death 1 year ) , occur frequently early survivor . Both rapid identification patient risk morbid outcome development novel therapy crucial improve outcomes sepsis . High density lipoprotein ( HDL ) defend sepsis-associated organ injury : 1 ) neutralize bacterial endotoxin , 2 ) modulate innate cellular immunity prevent release inflammatory cytokine , 3 ) prevent endothelial cell activation dysfunction . However , HDL become dysfunctional ( Dys-HDL ) set inflammation , lose protective function become pro-inflammatory . Our preliminary result demonstrate Dys-HDL present early sepsis persistent Dys-HDL elevation ( first 48 hour ) associate adverse outcome ( death , hospice nursing home care ) . The overall goal proposal investigate fully characterize role Dys-HDL diverse population patient CA HA-sepsis . The central hypothesis study structural functional change HDL sepsis associate persistent presence Dys-HDL well inflammation endothelial dysfunction lead acute organ dysfunction , CCI , morbid long-term outcome . To test , enroll 160 patient two-site , prospective , longitudinal , cohort study .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Patients meet recently update definition sepsis ( suspect confirm infection plus ≥ 2 SOFA point ) OR septic shock ( hypotension responsive 30 mL/kg IV fluid , vasopressor requirement , lactate ≥ 2 ) 23 treated institutional , evidencebased guideline ( EBG ) management bundle sepsis within 24 hour adopt site . ) significant traumatic brain injury ( evidence neurologic injury CT scan GCS &lt; 8 ) , b ) refractory shock ( likely death within 12 hour ) , c ) alternative/confounding diagnosis cause shock ( e.g. , myocardial infarction pulmonary embolus ) , ) uncontrollable source sepsis ( e.g. , irreversible disease state unresectable dead bowel ) , e ) patient deem futile care advance directive limit resuscitative effort , f ) severe CHF ( NY Heart Association Class IV ) , g ) ChildPugh Class B C liver disease , h ) know HIV CD4 count &lt; 200 cells/mm3 , ) organ transplant recipient immunosuppressive agent , j ) know pregnancy , k ) inability obtain informed consent , l ) diagnose disorder lipid metabolism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>sepsis</keyword>
	<keyword>septic shock</keyword>
	<keyword>cholesterol</keyword>
	<keyword>high density lipoprotein</keyword>
</DOC>